TORONTO - July 19, 2018 - (Newswire.com)
Clinical Evaluation Reports (CERs) and CE certifications under the EU’s previous Medical Device Directive 93/42 EEC (MDD) were historically based only on product equivalency. However, new expectations under MEDDEV 2.7/1 Rev 4 now present challenges for EU medical device manufacturers provided that clinical data expectations under the new Medical Device Regulation (MDR) require more in-depth assessments and increased expectations of Notified Bodies (NBs).
The EU Medical Device Regulation 2017/745 (MDR) substantially tightens the requirements for equivalence justification compared even to MEDDEV 2.7/1 Rev 4 and makes it now almost impossible to leverage a competitor’s clinical data. Although there remains significant uncertainty regarding the MDR – with many implementing and delegating acts to be drafted and approved – in the case of clinical evidence, MEDDEV 2.7/1 Rev 4 provides clear expectations for MDD compliance with Annex X and Annex 7 of the Active Implantable Device Directive 90/385/EEC (AIMD), as well as Art 61 and MDR Annex XIV.
In this live webinar, Paul Malinovski, NAMSA’s Manager of Medical Writing and Regulatory Services (EMEA), will examine the requirements listed in the MDR and MEDDEV 2.7/1 Rev 4, and discuss why device manufacturers shall not consider the CER a mandatory document for NBs or authorities, but rather as a crucial tool for a smooth transition for MDR and beyond.
Join this informative and interactive presentation on Tuesday, Aug. 7, 2018, at 10 a.m. EDT (3 p.m. BST/UK).
For more information about this complimentary webinar, visit EU MDR 2017/745: Optimizing Clinical Evaluation Reports within the Medical Device Lifecycle.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical and biotech companies, private and academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks, visit http://xtalks.com.
For information about hosting a webinar, visit http://xtalks.com/sponsorship.ashx.
Contact:
Nima Rajan
Tel: +1 (416) 977-6555 ext 352
Email: nrajan@xtalks.com
Related Links
Webinar Details
About NAMSA
Related Images
Press Release Service by Newswire.com
Original Source: EU MDR 2017/745: Optimizing Clinical Evaluation Reports Within the Medical Device Lifecycle, New Webinar Hosted by Xtalks
